Investor Announcements - 2016

Pages:

TR-1 notification of major interest in shares

15^th Jul 2016

TR-1 notification of major interest in shares

12^th Jul 2016

Directorate Change

11^th Jul 2016

EKF Diagnostics announces the appointment of Carl Dominic Contadini, an Operational Adviser to Harwood Capital LLP, as Non-Executive Director with immediate effect.

Trading update

6^th Jul 2016

EKF Diagnostics Holdings plc provides the following update on trading for the six months ended 30 June 2016.

TR-1 notification of major interest in shares

22^nd Jun 2016

Archive

Mount Sinai investments related
RNS announcements

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

Cancellation of Treasury Shares and TVR

EKF announces the completion of the Company’s buyback programme

Result of AGM and Voting results

EKF announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

AGM Statement

EKF provides an update to shareholders ahead of its Annual General Meeting

PDMR/Director Dealings & Holding(s) in Company

EKF announces that the Board of EKF has been informed that on Thursday 28 April 2022, certain funds connected to Christopher Mills, Non-executive Chairman.

Posting of Annual Report & Accounts and Notice of Annual General Meeting

EKF confirms that the Annual Report and Accounts for the year ended 31 December 2021 and the Notice of the 2022 Annual General Meeting have now been published